Primecap Cuts Amgen Stake by 23.9% as Other Funds Add Shares
Primecap Management Co. reduced its Amgen stake by 23.9% in the second quarter, selling 2,117,167 shares, leaving 6,756,962 shares. White Knight, Trajan Wealth, and Van Hulzen added shares, while insiders sold 6,222 shares valued at $2.54M. Analyst views were mixed, including a Wall Street Zen move from hold to buy and a Canaccord hold with a higher $384 target.